{"id":"https://genegraph.clinicalgenome.org/r/1b050a7d-4e60-4e57-a703-5ce4988bf321v1.1","type":"EvidenceStrengthAssertion","dc:description":"*NFATC1* was first reported in relation to autosomal dominant congenital heart disease in 2012 (Abdul-Sater et al., PMID:23226213). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, and phenotypic variability. Therefore, the following disease entities have been lumped into one disease entity: Bicuspid aortic valve, tricuspid atresia, atrioventricular septal defect, congenital heart disease, tetralogy of Fallot, and ventricular septal defect. Eight unique missense variants have been reported in eight probands in six publications (PMIDs: 23226213, 34363434, 25260786, 30007050, 34426522, 32859249). However, all the missense variants had high minor allele frequency (> 0.00001) in gnomAD v2.1.1 and very low REVEL score, so they were not scored. All of the experimental evidence was performed with these variants, and therefore was not scored (PMIDs: 30007050, 23226213, 34363434). In summary, the evidence supporting the relationship between *NFATC1* and autosomal dominant congenital heart disease has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *NFATC1* plays in this disease. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 7/17/2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1b050a7d-4e60-4e57-a703-5ce4988bf321","GCISnapshot":"https://genegraph.clinicalgenome.org/r/f8524125-b985-4fa5-bf8c-2cb6202964eb","calculatedEvidenceStrength":"NoKnownDiseaseRelationship","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/f8524125-b985-4fa5-bf8c-2cb6202964eb_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2023-07-17T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/f8524125-b985-4fa5-bf8c-2cb6202964eb_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2023-09-18T17:43:52.553Z","role":"Publisher"}],"curationReasonDescription":"Lack of convincing genetic and experimental evidence","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f8524125-b985-4fa5-bf8c-2cb6202964eb_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c9ffb26-6589-4ad5-9c8d-57b45de13af3","type":"EvidenceLine","dc:description":"The gnomAD MAF is 0.0001579 (4/25336) in South Asian and the REVEL score is 0.042","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c9ffb26-6589-4ad5-9c8d-57b45de13af3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30007050","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e4b4574-0137-45ce-8bcc-dab578bbda88","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001278669.2(NFATC1):c.1100C>T (p.Ala367Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9009037"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b49b540b-d717-4721-bda2-8f3ce6c3a21d","type":"EvidenceLine","dc:description":"The gnomAD MAF is 0.001258 (158/125552) in European (non-Finnish) and the REVEL score is 0.206","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b49b540b-d717-4721-bda2-8f3ce6c3a21d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30007050","allele":{"id":"https://genegraph.clinicalgenome.org/r/fb07d259-a57c-46c4-a171-57b6962c2b7f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001278669.2(NFATC1):c.628G>A (p.Val210Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9008876"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/aaac1304-00fa-4f3e-95f9-b0ac52702d41","type":"EvidenceLine","dc:description":"The gnomAD MAF is 0.0001579 (4/25336) in South Asian and the REVEL score is 0.042, so it was not scored\n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aaac1304-00fa-4f3e-95f9-b0ac52702d41_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34426522","allele":{"id":"https://genegraph.clinicalgenome.org/r/5e4b4574-0137-45ce-8bcc-dab578bbda88"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3be663e9-6651-4693-836c-8305b3981efc","type":"EvidenceLine","dc:description":"The gnomAD MAF is 0.001258 (158/125552) in European (non-Finnish) and the REVEL score is 0.206","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3be663e9-6651-4693-836c-8305b3981efc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25260786","allele":{"id":"https://genegraph.clinicalgenome.org/r/fb07d259-a57c-46c4-a171-57b6962c2b7f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d9d3c917-562d-4798-9e1c-6ef058ddda4f","type":"EvidenceLine","dc:description":"The gnomAD MAF is 0.0003431 (44/128248) in European (non-Finnish) and the REVEL score is 0.249","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9d3c917-562d-4798-9e1c-6ef058ddda4f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25260786","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ced449c-85cb-46d8-9d2d-55ca15e61b5f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001278669.2(NFATC1):c.230C>T (p.Pro77Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9008775"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0a93d57d-16fa-4a43-ad2b-075a228eff4c","type":"EvidenceLine","dc:description":"The variant has a gnomAD MAF of 0.00005648 (2/35410) in Latino/Admixed American and a REVEL score of 0.163, which does not meet our pathogenic criteria. The proband was also identified with the p.(Pro86Leu) variant in the TBX1 gene\n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a93d57d-16fa-4a43-ad2b-075a228eff4c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30007050","allele":{"id":"https://genegraph.clinicalgenome.org/r/a317e046-7df4-4745-a1ca-5725fdc5ec3d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001278669.2(NFATC1):c.2086G>A (p.Ala696Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA303728016"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/76b9e764-fc7a-4ce1-87d4-e553310c5929","type":"EvidenceLine","dc:description":"The gnomAD MAF is 0.0007660 (19/24804) in African/African American which is above our threshold of 0.00001, and the REVEL score is 0.138, predicting no impact. ","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76b9e764-fc7a-4ce1-87d4-e553310c5929_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23226213","allele":{"id":"https://genegraph.clinicalgenome.org/r/ffd49b32-2dec-4f73-bb49-888e3684391c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001278669.2(NFATC1):c.197C>T (p.Pro66Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9008764"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5edf0306-cbf1-48a3-be59-9c263f42e807","type":"EvidenceLine","dc:description":"The variant is absent from gnomAD v.2.1.1, however the REVEL score of 0.183 is too low","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5edf0306-cbf1-48a3-be59-9c263f42e807_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23226213","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a80be6d-de5b-4df5-842b-cd91e1e078c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001278669.2(NFATC1):c.2101A>C (p.Ile701Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA402825411"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4882870c-2b72-4d45-884d-1b7312aa8a75","type":"EvidenceLine","dc:description":"The variant was identified in healthy mother. The gnomAD MAF is 0.00005099 (1/19610) in East Asian, which is above the threshold of 0.00001. The REVEL score of 0.227 is also too low\n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4882870c-2b72-4d45-884d-1b7312aa8a75_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34363434","allele":{"id":"https://genegraph.clinicalgenome.org/r/210dd8c7-ff4c-48c7-a033-59fedc1d5ff5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001278669.2(NFATC1):c.964G>A (p.Asp322Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9008994"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d6e213f0-c404-4176-9819-f13fe4c1ab5e","type":"EvidenceLine","dc:description":"The gnomAD MAF is 0.00706 (118/16712) in European (Finnish), and the REVEL score is 0.115, so the variant was not scored\n","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6e213f0-c404-4176-9819-f13fe4c1ab5e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32859249","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc55b8d2-ea75-4dc8-bae5-0a0f8a20d91d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001278669.2(NFATC1):c.2383G>A (p.Gly795Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9009618"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f8524125-b985-4fa5-bf8c-2cb6202964eb_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0}],"evidenceStrength":"Disputed","sequence":6877,"specifiedBy":"GeneValidityCriteria9","strengthScore":0,"subject":{"id":"https://genegraph.clinicalgenome.org/r/lkkR2Pbc7dI","type":"GeneValidityProposition","disease":"obo:MONDO_0005453","gene":"hgnc:7775","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_f8524125-b985-4fa5-bf8c-2cb6202964eb-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}